A new study led by Bucknell University Professor Karlo Malaga, biomedical engineering, has identified key insights into optimizing deep brain stimulation (DBS) for Parkinson's disease patients.
A groundbreaking international clinical trial has been testing an implanted adaptive deep brain stimulation (aDBS) device as a treatment therapy for Parkinson’s.
MinnPost’s journalists are out in the community to report on the things that are happening in Minnesota. Your support right now will help fund their work AND keep our news paywall-free. While a ...
Novel study by researchers at the Rambam Health Care Campus could help 21 million people worldwide suffering from the severe ...
HOUSTON, TX, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (NXL) (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the brain, ...
Brain implants that deliver electric pulses can ease depression in people who aren't responding to psychiatric drugs, a new study says. Half of a small group of people who received brain implants ...
Deep brain stimulation appears to help some people with depression Half of a small group of people with treatment-resistant depression found significant relief from brain implants that provide ...
Abbott has launched a pivotal clinical trial to see if its deep-brain stimulation approach can make headway against treatment-resistant depression. The company previously collected green lights for ...
ROCHESTER, Minn. — A study published in Brain Communications highlights a new approach to treating drug-resistant epilepsy. Researchers at Mayo Clinic have developed an innovative deep brain ...